Current Trends In Medical And Clinical Case Reports (ISSN:2769-7088)

Editor Name: Dr. Vivek Lal

Designation: Professor

Country: India

University: Academic Council & Quality Assurance Committee

Email: ltcolvivek@gmail.com

BIOGRAPHY

▪ As a Resident: At AFMC Pune: 03 years

▪ As an Assistant Professor: At AFMC Pune and Command Hospital Kolkata: 05 years

▪ As an Associate Professor: At AFMC Pune, Azeezia Medical College, Kollam: 3 years 6 months.

▪ As a Full Professor: At AIMU, St Lucia and AMCRC Mauritius: 2 years

▪ As an Associate Professor of Pharmacology: At two military teaching hospitals: 05 years

▪ As an Associate Professor of Pharmacology : At King Faisal University, Al Ahsa, Saudi Arabia: 3 years 6 months.

RESEARCH INTEREST: Pharmacology, Therapeutics, Toxicology, Toxinology, Medical Education, Research methodology Allied disciplines: General Medicine & Surgery with allied subjects.

Sharma LR, Lal Vivek, Simpson ID. Snakes of Medical Significance in India: The First Reported Case of Envenoming by the Levantine Viper (Macroviperalebetina). Wilderness Environ Med. 2008; 19:195-198

▪ Kairi JK, Lal Vivek et al. Poisoning and envenomation registry : Analysis of 200 case reports. MJAFI. 2011;Vol 67 No 2:131-137

▪ Lal Vivek. New Drugs in the pipeline: A review. Int J Med Res Health Sci. 2013;2(2):250-253

▪ Lal Vivek. Pharmacovigilance in Developing Nations: Are we doing enough? JIST.2013;Vol 9(1):17-22

▪ Lal, V. (2015), "Ischemic heart disease - part 1 of 2", in Topical Talks: Talks of interest in the biomedical and life sciences, The Biomedical & Life Sciences Collection, Henry Stewart Talks Ltd, London (online at http://hstalks.com/?t=BL1004022-Lal)

▪ Lal, V. (2015), "Ischemic heart disease - part 2 of 2", in Topical Talks: Talks of interest in the biomedical and life sciences, The Biomedical & Life Sciences Collection, Henry Stewart Talks Ltd, London (online at http://hstalks.com/?t=BL1004093-Lal)

▪ Lal, V. “New Drug Development in Type-2 Diabetes Mellitus: Current and future trends – An overview.” ClinExpPharmacol 2015, 5:4http://dx.doi.org/10.4172/2161- 1459.S1.007

▪ Conducted a workshop on “Current and future trends in the pharmacotherapy of Type-2 Diabetes Mellitus” in the World Congress of Pharmacology at Brisbane, Australia, on 20-22 July 2015. Focus on restoring glucose homeostasis in diabetics (highlighted in J ClinExpPharmacol 2015)

▪ Lal, V. (2017), Fibrinolytic drug therapy in the management of intravascular thrombosis, especially acute myocardial infarction – A Review. J PharmacolClin Res. 2016; 2(4): 555593.

▪ Other Publications & presentations: On pharmacokinetic drug interactions, pharmacodynamics studies, toxicity studies (1997-2007), Poison Information Centres etc.